MRK vs WORX · P/E 33, rev $16.61B vs rev $1.5M
Merck & Company Inc (MRK) versus Scworx Corp (WORX) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Scworx Corp (WORX) is a health information services company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported WORX revenue for 2026-06-30 was $1.5M. Net income was -$294.7K. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. WORX currently screens at market cap $1.6M.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. WORX currently screens at market cap $1.6M.
Not investment advice. Open the MRK and WORX stock pages for the full models.
Not investment advice.